These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7421660)

  • 1. Haemorrhagic cystitis treated with epsilon-aminocaproic acid.
    Aroney RS; Dalley DN; Levi JA
    Med J Aust; 1980 Jul; 2(2):92. PubMed ID: 7421660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravesical epsilon aminocaproic acid in management of intractable bladder hemorrhage.
    Singh I; Laungani GB
    Urology; 1992 Sep; 40(3):227-9. PubMed ID: 1523745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myopathy associated with epsilon-aminocaproic acid (EACA) therapy. Report of two cases.
    MacKay AR; Sang U H; Weinstein PR
    J Neurosurg; 1978 Oct; 49(4):597-601. PubMed ID: 690689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A method for monitoring antifibrinolytic therapy in patients with ruptured intracranial aneurysms.
    Burchiel KJ; Schmer G
    J Neurosurg; 1981 Jan; 54(1):12-5. PubMed ID: 7463112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of probenecid on the kinetics of epsilon-aminocaproic acid.
    Dvorchik BH; Katlic KL; Hayes AH; Eyster ME
    Clin Pharmacol Ther; 1980 Aug; 28(2):223-8. PubMed ID: 7398189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of short-term ε-aminocaproic acid treatment on patients undergoing endovascular coil embolization following aneurysmal subarachnoid hemorrhage.
    Malekpour M; Kulwin C; Bohnstedt BN; Radmand G; Sethia R; Mendenhall SK; Weyhenmeyer J; Hendricks BK; Leipzig T; Payner TD; Shah MV; Scott J; DeNardo A; Sahlein D; Cohen-Gadol AA
    J Neurosurg; 2017 May; 126(5):1606-1613. PubMed ID: 27315025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative determination of plasma fibrinolytic activity in patients with ruptured intracranial aneurysms who are receiving epsilon-aminocaproic acid: relationship of possible complications of therapy to the degree of fibrinolytic inhibition.
    Burchiel KJ; Hoffman JM; Bakay RA
    Neurosurgery; 1984 Jan; 14(1):57-63. PubMed ID: 6537999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epsilon aminocaproic acid and the control of post-prostatectomy bleeding: a prospective double-blind study.
    Smith RB; Riach P; Kaufman JJ
    J Urol; 1984 Jun; 131(6):1093-5. PubMed ID: 6539381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Control of bleeding after renal biopsy with epsilon-amino-caproic acid.
    Savdie E; Mahony JF; Storey BG
    Br J Urol; 1978 Feb; 50(1):8-11. PubMed ID: 630206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EPSILON-AMINOCAPROIC ACID (EACA).
    NAHUM LH
    Conn Med; 1964 Sep; 28():641-5. PubMed ID: 14201313
    [No Abstract]   [Full Text] [Related]  

  • 11. Myoglobinuria following epsilon-aminocaproic acid (EACA) therapy. Case report.
    Brodkin HM
    J Neurosurg; 1980 Nov; 53(5):690-2. PubMed ID: 7431078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical aminocaproic acid significantly reduces the incidence of secondary hemorrhage in traumatic hyphema in the rabbit model.
    Allingham RR; Crouch ER; Williams PB; Catlin JC; Loewy DM; Jacobson J
    Arch Ophthalmol; 1988 Oct; 106(10):1436-8. PubMed ID: 3178555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intra-alveolar epsilon-aminocaproic acid for the control of post-extraction bleeding in anticoagulated patients: randomized clinical trial.
    da Silva RV; Gadelha TB; Luiz RR; Torres SR
    Int J Oral Maxillofac Surg; 2018 Sep; 47(9):1138-1144. PubMed ID: 29602626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epsilon-aminocaproic acid and recurrent subarachnoid hemorrhage: a clinical trial.
    Shucart WA; Hussain SK; Cooper PR
    J Neurosurg; 1980 Jul; 53(1):28-31. PubMed ID: 7411206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epsilon-aminocaproic acid (EACA).
    Griffin JD; Ellman L
    Semin Thromb Hemost; 1978; 5(1):27-40. PubMed ID: 568312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and laboratory investigation of the effects of epsilon-aminocaproic acid on hemostasis.
    Green D; Ts'ao CH; Cerullo L; Cohen I; Ruo TI; Atkinson AJ
    J Lab Clin Med; 1985 Mar; 105(3):321-7. PubMed ID: 2982982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of epsilon-aminocaproic acid during peritoneal dialysis.
    Fish SS; Pancorbo S; Berkseth R
    J Neurosurg; 1981 Jun; 54(6):736-9. PubMed ID: 7241183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-biopsy bleeding in renal allograft: successful treatment with epsilon aminocaproic acid.
    Salcedo JR; Silverstein CE
    J Urol; 1982 Apr; 127(4):783. PubMed ID: 7040701
    [No Abstract]   [Full Text] [Related]  

  • 19. Epsilon aminocaproic acid prevents bleeding in severely thrombocytopenic patients with hematological malignancies.
    Antun AG; Gleason S; Arellano M; Langston AA; McLemore ML; Gaddh M; el Rassi F; Bernal-Mizrachi L; Galipeau J; Heffner LT; Winton EF; Khoury HJ
    Cancer; 2013 Nov; 119(21):3784-7. PubMed ID: 23921838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [FIBRINOLYSIS AND EPSILON-AMINOCAPROIC ACIDS].
    SAMAMA M; MARCHAL G; BILSKI-PASQUIER G; DUHAMEL G; CASUBOLO
    Sangre (Barc); 1964; 41():367-70. PubMed ID: 14248818
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.